John M. Harrold

GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys

Shu-Chen Lu, Michelle Chen, Larissa Atangan et al. · Cell Reports Medicine · 2021 · 85 citations · Full text

Pharmacy, Endocrinology, Pharmacology +17

Clinically relevant cancer chemotherapy dose scheduling via mixed-integer optimization

John M. Harrold, Robert S. Parker · Computers & Chemical Engineering · 2009 · 60 citations

Medicine, Oncology, Chemotherapy +13

Semi-mechanistic Population Pharmacokinetic Model of Multivalent Trastuzumab Emtansine in Patients with Metastatic Breast Cancer

Vaishali L. Chudasama, Franziska Schaedeli Stark, John M. Harrold et al. · Clinical Pharmacology & Therapeutics · 2012 · 51 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +17

Interspecies Scaling of Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Type I Interferons

Leonid Kagan, Anson K. Abraham, John M. Harrold et al. · Pharmaceutical Research · 2010 · 48 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

The Role of Corporate Identity in Merger and Acquisition Activity

T.C. Melewar, John M. Harrold · Journal of General Management · 2000 · 43 citations

Business, Strategic Management, Strategy +16